Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Public ClinicalTrials.gov record NCT00867113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Non-Randomized, Open-Label Multicenter Study of 5 Year Adjuvant Imatinib Mesylate (Gleevec®) in Patients at Significant Risk for Recurrence Following Complete Resection of Primary Gastrointestinal Stromal Tumor (GIST)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase II, non-randomized, open-label, multi-center study conducted in the USA. The purpose of this trial is to evaluate the use of long term adjuvant imatinib mesylate in patients at significant risk for recurrence following complete resection of primary GIST.
Study identification
- NCT ID
- NCT00867113
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2009 (Actual)
- Primary completion
- Dec 20, 2016 (Actual)
- Completion
- Dec 20, 2016 (Actual)
- Last update posted
- Mar 14, 2018
2009 – 2016
United States locations
- U.S. sites
- 21
- U.S. states
- 19
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego - Moores Cancer Center Moores UCSD Cancer Center (31) | La Jolla | California | 92093-0658 | — |
| University of Colorado University of Colorado | Aurora | Colorado | 80045 | — |
| Washington Hospital Center Department of Medical Oncology | Washington D.C. | District of Columbia | 20010 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| Longstreet Cancer Center | Gainesville | Georgia | 30501 | — |
| Kootenai Medical Center Kootenai Cancer Cancer | Coeur d'Alene | Idaho | 83814 | — |
| North Shore University Health System | Evanston | Illinois | 60201 | — |
| Dana Farber Cancer Institute Dana-Farber | Boston | Massachusetts | 02215 | — |
| Karmanos Cancer Institute Karmonos Cancer Instit. (40) | Detroit | Michigan | 48201 | — |
| Washington University School of Medicine Center for Advanced Medicine | St Louis | Missouri | 63110 | — |
| Southern Nevada Cancer Research Foundation S. Nevada Cancer Res (2) | Las Vegas | Nevada | 89106 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering (7) | New York | New York | 10021 | — |
| Duke University Medical Center Duke University Med Ctr (8) | Durham | North Carolina | 27710 | — |
| Oregon Health & Science University OHS University | Portland | Oregon | 97239 | — |
| Penn State University / Milton S. Hershey Medical Center Penn Stat University | Hershey | Pennsylvania | 17033-0850 | — |
| Roger Williams Medical Center Medical Center | Providence | Rhode Island | 02908 | — |
| Kingport Hematology Oncology | Kingsport | Tennessee | 37660 | — |
| MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (4) | Houston | Texas | 77030 | — |
| South Texas Oncology and Hematology, PA South Texas Onc/Hem | San Antonio | Texas | 78259 | — |
| Virginia Oncology Associates Viriginia Oncology Assoc. | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00867113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00867113 live on ClinicalTrials.gov.